Scarica l'app Stockscreener
127.15
4.75%
5.75
Dopo l'orario di chiusura:
127.15
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RGEN Giù?
Forum
Previsione
Precedente Chiudi:
$121.40
Aprire:
$122.29
Volume 24 ore:
881.65K
Relative Volume:
1.09
Capitalizzazione di mercato:
$7.15B
Reddito:
$633.51M
Utile/perdita netta:
$-8.10M
Rapporto P/E:
-410.16
EPS:
-0.31
Flusso di cassa netto:
$131.26M
1 W Prestazione:
+13.44%
1M Prestazione:
-2.32%
6M Prestazione:
-13.00%
1 anno Prestazione:
-22.71%
Intervallo 1D:
$120.36
$127.56
Intervallo di 1 settimana:
$111.15
$127.56
Portata 52W:
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
Nome
Repligen Corp
Settore
Industria
Telefono
(781) 449-9560
Indirizzo
41 SEYON STREET, WALTHAM, MA
Confronta RGEN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
127.15 | 6.29B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
482.35 | 169.15B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.18B | 21.39B | 1.59B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
288.28 | 41.63B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
86.48 | 41.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.28B | 2.90B | 467.20M | 306.90M | 6.37 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-06-24 | Iniziato | Barclays | Overweight |
| 2025-04-29 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Iniziato | Evercore ISI | In-line |
| 2025-02-10 | Iniziato | TD Cowen | Buy |
| 2024-12-17 | Iniziato | Canaccord Genuity | Hold |
| 2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-26 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Iniziato | Guggenheim | Neutral |
| 2023-12-04 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Iniziato | Wells Fargo | Overweight |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-03-28 | Iniziato | The Benchmark Company | Buy |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2021-10-14 | Iniziato | Exane BNP Paribas | Outperform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-07 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-23 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-11-01 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Iniziato | SVB Leerink | Outperform |
| 2019-08-28 | Reiterato | First Analysis Sec | Outperform |
| 2019-08-23 | Ripresa | Stephens | Overweight |
| 2019-07-22 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Aggiornamento | CL King | Neutral → Buy |
| 2018-11-12 | Downgrade | CL King | Buy → Neutral |
| 2018-09-26 | Iniziato | H.C. Wainwright | Neutral |
| 2017-12-08 | Iniziato | Citigroup | Buy |
| 2017-12-05 | Iniziato | JP Morgan | Overweight |
| 2017-11-13 | Iniziato | CL King | Buy |
| 2017-10-02 | Aggiornamento | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Iniziato | William Blair | Outperform |
| 2017-02-13 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
Mostra tutto
Repligen Corp Borsa (RGEN) Ultime notizie
Using fundamentals and technicals on Repligen CorporationPortfolio Gains Report & Proven Capital Preservation Methods - Newser
Why Repligen Corporation stock attracts strong analyst attentionWatch List & AI Driven Stock Price Forecasts - Newser
Can machine learning forecast Repligen Corporation recoveryPortfolio Return Summary & Real-Time Buy Signal Notifications - Newser
Will earnings trigger a reversal in Repligen CorporationTrade Signal Summary & Low Risk Entry Point Guides - Newser
Repligen Corporation stock prediction for this weekAsset Growth Pattern and Return Summary - Newser
How to monitor Repligen Corporation with trend dashboardsFree Sector Based Breakout Stock Forecast - Newser
AMN Healthcare Services, NeoGenomics, Acadia Healthcare, BrightSpring Health Services, and Repligen Shares Are Soaring, What You Need To Know - FinancialContent
Repligen director Madaus buys $201k in shares By Investing.com - Investing.com South Africa
Repligen director Madaus buys $201k in shares - Investing.com
RGEN Q2 Deep Dive: Chromatography and Filtration Drive Growth, Guidance Lifted Amid New Modalities Uncertainty - Yahoo Finance
5 Must-Read Analyst Questions From Repligen’s Q2 Earnings Call - Yahoo Finance
Using economic indicators to assess Repligen Corporation potentialSmart Forecast Signals from AI Models - Newser
Will Repligen Corporation benefit from macro trendsFree Portfolio Diversification Stock Ideas - Newser
Can trapped investors hope for a rebound in Repligen CorporationShort Term Opportunity Finder with Tools - Newser
Will Repligen Corporation rebound enough to break evenFree Pattern Breakout Entry Stock Forecast - Newser
Repligen Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Volatility clustering patterns for Repligen CorporationBuy Signal System Based on Price Action - Newser
How Repligen Corporation stock performs during market volatilityAutomated AI Forecast with Trading Alerts - Newser
Exit strategy if you’re trapped in Repligen CorporationSafe Entry Zone Based on Chart Analysis - Newser
Repligen CorporationCommon Stock (Nasdaq:RGEN) Stock Quote - FinancialContent
Sector ETF performance correlation with Repligen CorporationPattern Recognition Tool for ROI Investors - Newser
Decoding Repligen Corp (RGEN): A Strategic SWOT Insight - GuruFocus
Live market analysis of Repligen CorporationDaily Entry Opportunity Forecasting Tool - Newser
REPLIGEN CORP SEC 10-Q Report - TradingView
Pattern recognition hints at Repligen Corporation upsideFree Fast Gaining Stock Screener Report - Newser
Long term hold vs stop loss in Repligen CorporationFree Expert Verified Stock Trade Ideas - Newser
Repligen (NASDAQ:RGEN) Investors Are Sitting on a Loss of 53% If They Invested Three Years Ago - 富途牛牛
Visual analytics tools that track Repligen Corporation performanceInvestment Roadmap for High Potential Stocks - Newser
Fund Update: GENEVA CAPITAL MANAGEMENT LLC added 343,991 shares of REPLIGEN ($RGEN) to their portfolio - Quiver Quantitative
What Fibonacci levels say about Repligen Corporation reboundFree Access to Smart Investment Tips - Newser
Geneva Capital Management LLC Buys 7,958 Shares of Repligen Corporation (NASDAQ:RGEN) - Defense World
Why is Repligen Corporation stock attracting strong analyst attentionUnlock exclusive trading strategies for gains - Jammu Links News
Can Repligen Corporation recover in the next quarterBuy Signal Forecast With Short-Term Data - Newser
William Blair Analysts Raise Earnings Estimates for Repligen - Defense World
Pacer Advisors Inc. Cuts Stake in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Corporation (NASDAQ:RGEN) Shares Acquired by Nicolet Advisory Services LLC - Defense World
Blueshift Asset Management LLC Takes $458,000 Position in Repligen Corporation (NASDAQ:RGEN) - Defense World
TD Asset Management Inc Has $6.51 Million Position in Repligen Corporation (NASDAQ:RGEN) - Defense World
Evaluating Repligen Corporation with trendline analysisWatchlist Generator With Real-Time Entry - Newser
Q3 Earnings Forecast for Repligen Issued By Leerink Partnrs - Defense World
XTX Topco Ltd Buys 3,295 Shares of Repligen Corporation (NASDAQ:RGEN) - Defense World
Wealthquest Corp Takes Position in Repligen Corporation (NASDAQ:RGEN) - Defense World
Royal Bank Of Canada Raises Repligen (NASDAQ:RGEN) Price Target to $204.00 - Defense World
Repligen Stock Outlook: Risk Skewed To The Downside Through 2026 - Benzinga
Repligen (RGEN) Partners with Novasign to Enhance Filtration Systems - GuruFocus
Repligen Corporation (NASDAQ:RGEN) Q2 2025 Earnings Call Transcript - Insider Monkey
Repligen partners with Novasign to enhance bioprocessing systems - Investing.com
Repligen partners with Novasign to enhance bioprocessing systems By Investing.com - Investing.com Canada
Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization - Yahoo Finance
Repligen Corporation (NASDAQ:RGEN) Shares Sold by Norden Group LLC - Defense World
Repligen Corp Azioni (RGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Repligen Corp Azioni (RGEN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hunt Anthony | Director |
May 15 '25 |
Sale |
123.71 |
26,447 |
3,271,688 |
109,854 |
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):